Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

Cyclophosphamide-induced cytogenetic effects in mouse bone marrow and spleen cells in in vivo and in vivo/in vitro assays.

Authors
Krishna-G; Nath-J; Petersen-M; Ong-T
Source
Teratog, Carcinog, Mutagen 1987 Jan; 7(2):183-195
NIOSHTIC No.
00169859
Abstract
The comparative cytogenetic results of in-vivo and in-vivo/in-vitro studies in mouse bone marrow and spleen cells were evaluated after treatment with varying doses of cyclophosphamide (50180) (CPA). CPA was injected intraperitoneally at dosages of 10, 20, or 40mg/kg for the sister chromatid exchange (SCE) study and at 20, 40, and 60mg/kg for the chromosomal aberration study. In-vivo assays involved preparation and analysis of cells directly from animals, while in- vivo/in-vitro assays involved cell culture prior to analysis. CPA caused dose related increases in both cytogenetic end points, SCEs and chromosomal aberrations. A significant difference in induced SCEs was noted when comparing findings of in-vivo to in-vivo/in- vitro SCE tests. A consistently higher SCE response was noted in in- vivo/in-vitro than in-vivo studies. These differences arose in part from cell culturing and nonculturing effects. While no organ difference was seen in-vivo, spleen cells were more sensitive than bone marrow in the in-vivo/in-vitro condition. When comparing the findings of the two methods, a significant difference was also noted in the number of induced aberrant cells and in induced aberrations with gaps and without gaps. Both conditions resulted in linear relationships between CPA dose and cytogenetic end point, and positive in-vivo assays were correlated with positive in-vivo/in- vitro assays. The authors conclude that these methods need further evaluation using other chemicals, species, organs, and genetic end points to determine effectiveness for human biological monitoring.
Keywords
NIOSH-Author; Antineoplastic-agents; Laboratory-animals; Chromosome-damage; Biological-monitoring; Screening-methods; In-vivo-studies; Genetics; Bone-marrow; Splenic-tissue; Author Keywords: mice; sister chromatid exchanges; chromosomal aberrations; comparative genotoxicity; animal model; primary cell culture
CODEN
TCMUD8
CAS No.
50-18-0
Publication Date
19870101
Document Type
Journal Article
Fiscal Year
1987
NTIS Accession No.
NTIS Price
Issue of Publication
2
ISSN
0270-3211
NIOSH Division
DRDS
Source Name
Teratogenesis, Carcinogenesis, and Mutagenesis
State
WV
TOP